event,time
65 years old ,0
    male ,0
    admitted to the hospital ,0
    non-ischaemic cardiomyopathy ,0
    left ventricular ejection fraction 20% ,0
    guideline-directed medical therapy ,0
    bisoprolol 5 mg PO o.d. ,0
    candesartan 4 mg PO o.d. ,0
    primary prevention implantable cardioverter-defibrillator ,0
    New York Heart Association class II ,-120
    paroxysmal atrial fibrillation ,0
    treated with apixaban ,0
    previous cerebrovascular accident ,0
    hypertension ,0
    dyslipidaemia ,0
    depression ,0
    presented with persistent epigastric abdominal pain ,0
    presented with fatigue ,0
    blood pressure 112/81 mmHg ,0
    heart rate 70 b.p.m. ,0
    respiratory rate 18 breaths per minute ,0
    jugular venous pressure 5–6 cm ,0
    peripheral oedema 1+ ,0
    lactate 5.6 mmol/L ,0
    creatinine 125 µmol/L ,0
    eGFR 60 mL/min/1.73 m2 ,0
    alanine transaminase 174 IU/L ,0
    transthoracic echocardiography ,0
    left ventricular function 11% ,0
    mild right ventricular dysfunction ,0
    intravenous furosemide infusion ,0
    home medications held ,0
    bisoprolol held ,0
    candesartan held ,0
    acute kidney injury ,192
    creatinine 176 µmol/L ,192
    eGFR 41 mL/min/1.73 m2 ,192
    alanine transaminase 350 IU/L ,192
    aspartate transaminase 913 IU/L ,192
    international normalized ratio 4.4 ,192
    lactate normalized to 1.7 mmol/L ,192
    heart rate 86 b.p.m. ,192
    blood pressure 103/66 mmHg ,192
    started bisoprolol 2.5 mg PO o.d. ,192
    started sacubitril/valsartan 24/26 mg PO b.i.d. ,192
    developed progressive shock ,216
    creatinine 476 µmol/L ,216
    eGFR 12 mL/min/1.73 m2 ,216
    hypotension ,216
    norepinephrine 0.28 µg/kg/min ,216
    dobutamine 18.7 µg/kg/min ,216
    transferred to tertiary academic centre ,240
    right heart catheterization ,240
    pulmonary capillary wedge pressure 24 mmHg ,240
    cardiac index 5.7 L/min/m2 ,240
    systemic vascular resistance 297 dyne/s/cm5 ,240
    diagnosed vasoplegic shock secondary to sacubitril/valsartan ,240
    sepsis ruled out ,240
    adrenal insufficiency ruled out ,240
    fulminant liver failure ruled out ,240
    neurogenic cause ruled out ,240
    vasoplegic shock resolved ,336
    creatinine normalized to 95 µmol/L ,336
    eGFR 84 mL/min/1.73 m2 ,336
    norepinephrine weaned off ,336
    right heart catheterization shows resolving vasodilatory shock ,360
    predominant cardiogenic shock ,360
    dobutamine continued ,360
    intravenous furosemide infusion started ,360
    dobutamine weaned off ,408
    hydralazine uptitration ,408
    spironolactone uptitration ,408
    bisoprolol initiated ,624
    ramipril initiated ,768
    discharged ,816
    net 25 kg weight loss ,816
    creatinine 148 µmol/L ,816
    eGFR 53 mL/min/1.73 m2 ,816
    sacubitril/valsartan discontinued ,816
    hyperkalaemia ,816
    New York Heart Association class II ,20160
